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Abstract 
A series of methoxy-4’-amino chalcone derivatives were tested for their antimicrobial activities against Escherichia coli ATCC 
25923, Staphylococcus aureus ATCC 25922 and Candida albicans ATCC 10231. Furthermore, their molecular interactions with 
dihydropteroate synthase (DHPS) of E. coli and S. aureus were studied with a docking experiment. Compound 4 ((E)-1-(4-
aminophenyl)-3-(2,3-dimethoxyphenyl)prop-2-en-1-one) exhibited the strongest activity, in which its activity was equal to 
sulfamerazine and sulfadiazine used as positive controls. In addition, it showed a good potential to be used as a wide spectrum 
antimicrobial agent. The in silico experiment showed that the prepared compounds had higher affinity to DHPS of S. aureus than 
to DHPS of E. coli. The tested compounds showed high similarity interaction with hydroxymethylpterin pyrophosphate (natural 
substrate of DHPS) in building intermolecular interactions. 
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1. Introduction 
Besides their simple preparation procedures, the increasing interest in chalcones is due to their various 
pharmacological potentials, such as antitumor1, anticancer2,3, antimalarial4, antihepatotoxic5, topoisomerase I 
inhibitor6, antinflammation7, antioxidant8 and antimicrobial activities9. 
Overuse and misuse of antimicrobial agents increases cases of antimicrobial drug resistance10. Sulfanilamide 
derivatives as the first generation of antibiotics and penicillin as one of the next generation (Patrick, 2001) have been 
replaced gradually by new generations of antibiotics11. However, the needs for more potential antibiotics are still to 
be explored due to the global health problems worldwide caused by antimicrobial resistance, especially in the 
developing countries. Suwito et al.14 have designed and synthesized a series of methoxy-4’-amino chalcone 
derivatives as antimicrobial agents mimicking the structure of PABA (p-amino benzoic acid) in the 4-amino benzoyl 
moiety12. PABA is a substrate of dihydropteroate synthase (DHPS) in the biosynthesis of 7,8-dihydropteroate, which 
is very important in folic acid biosynthesis needed for cell proliferation13. The rationale of the design was that the 
synthesized compounds could act as a competitive inhibitor of PABA.  
In this work we report the study of intermolecular interactions between the prepared compounds with DHPS to 
develop better understanding of the molecular interactions, so that in the future we can design compounds 
possessing better anti-microbial activities. 
2. Methods 
2.1. Synthesis of chalcone derivatives 
The target molecules (compound 1-7) were synthesized using the Claisen-Schmidt reaction as reported by Suwito 
et al.12 Structure characterization of the prepared compounds was based on spectroscopic evidence.  
2.2. Antimicrobial activity assay 
Seven prepared compounds were tested for their antimicrobial activities against Escherichia coli ATCC 25923, 
Staphylococcus aureus ATCC 25922 and Candida albicans ATCC 10231. The antimicrobial test was performed 
using the disc diffusion method and the diameter of the inhibition zone was observed. The data obtained were then 
analyzed statistically using the Kolmogorov-Smirnov test and the Kruskal-Wallis test. Sulfadiazine and 
sulfamerazine were used as positive controls.  
 
2.3 Software and program 
The ligand structures were drawn in ChemBioDraw Ultra 11.0. DS visualizer 2.5 (Accelerys, Inc., USA) and 
PyMOL (DeLano Scientific LLC, USA) were used to modify the ligand and to visualize the receptor structure and 
docking results. The preparation of the DHPS pdbqt file and determination of the grid box size and position were 
carried out using AutoDock Tools version 1.5.6. AutoDock 4 was the sole docking program employed in this 
work15. 
 
2.4 Preparation of the receptors and ligand structure 
The three-dimensional structure of DHPS of E. coli complexed with sulfanilamide was retrieved from the Protein 
Data Bank [PDB:1AJ0], while the three-dimensional structure of DHPS of S. aureus complexed with 6-
hydroxymethylpterin-diphosphate was downloaded from Protein Data Bank [PDB:1AD4]. The DHPS structure of E.
coli was prepared for molecular docking by removing the sulphate ions and saved as a pdb file for the docking 
experiment. The DHPS three-dimensional structure of S. aureus was prepared for the docking experiment by 
removing K+ and Mn2+ ions and then saved as pdb file for molecular docking. The ligand structures were drawn 
using ChemBioDraw Ultra 11.0, subsequently modified using DS visualizer 2.5 and saved as a pdb file. 
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2.5 Docking experiment 
Molecular docking was carried out using AutoDock 415. AutoDock Tools 1.5.6 was utilized to prepare the input 
pdbqt files of DHPS of E. coli and S. aureus and to set the size and center of the grid box. The E. coli DHPS binding 
site was set at 41.903 x 8.143 x 2.045 ǖ, while the S. aureus binding site was set at 33.106 x 8.125 x 41.335 ǖ in the 
dimensions of x, y, z using 1.000 Å spacing for E. coli and 3.75 Å spacing for S. aureus. The pdbqt input file 
required for AutoDock4 was prepared by AutoDock Tools 1.5.6. The predicted binding affinity (kcal/mol), which 
describes the binding strength between ligand and receptor, is calculated based on the scoring function employed in 
AutoDock4. A more negative binding affinity indicates stronger binding. The docking experiment was performed 
according to the procedures provided by the AutoDock4 protocol. 
3. Results and discussion 
3.1. Antimicrobial activity 
The compounds used in this work were methoxy-4’-amino chalcone derivatives, the molecular structures of 





The data of antimicrobial tests of the entire compounds against E. coli ATCC 25923, S. aureus ATCC 25922, 
and C. albicans ATCC 10231 have been reported.14 Dose dependence of the antimicrobial activity of the tested 
compound was observed. The higher the concentration of the tested compound, the larger the inhibition zone 
diameter.14 The effect of the substituent of the prepared chalcone derivatives without considering the variation of 
concentration toward its activity was studied and is reported in this article. Based on the Kolmogorov-Smirnov test, 
it was shown that the diameters of the inhibition zones were not normally distributed (Į = 0.05). The test was then 
followed with the Kruskal-Wallis test. The results of the tests are presented in Fig. 1.  
Based on the analysis using the Kruskal-Wallis test toward E. coli, sulfadiazine showed the strongest inhibition 
activity, followed by sulfamerazine, compound 7 and then compound 4. However, the inhibition activity of 
compound 7 did not differ significantly from sulfamerazine and compound 4. Statistical analysis of the antimicrobial 
test toward S. aureus showed that compound 4 exhibited the strongest activity. However its activity did not differ 
significantly from sulfamerazine. The inhibition activity of compounds 7, 1, 5, 3 and 2 also did not differ 
significantly from sulfadiazine. The inhibition activity analysis toward C. albicans showed that sulfadiazine 
possessed the strongest activity, although its activity did not differ significantly from compounds 5, 3 and 4. 
Structure-activity relationship analysis employing Kruskal-Wallis test gave us information that the amino group 
played an important role in the antimicrobial activity, while the methoxy group on ring B played a less significant 
role. Among the tested compounds, compound 4, (E)-1-(4-aminophenyl)-3-(2,3-dimethoxyphenyl)prop-2-en-1-one, 
exhibited a promising wide spectrum of antimicrobial activity as strong as the positive controls.  
 
Table 1. Structure of the tested chalcones 
Comp Ring B
1 2 3 4 5 6 
1 - OMe - - - - 
2 - - OMe - - - 
3 - - - OMe - - 
4 - OMe OMe - - - 
5 - OMe - OMe - - 
6 - OMe - - OMe - 
7 - - - - - - 





3.2. In silico analysis 
This article discusses the molecular interaction between DHPS of E. coli and S. aureus with the title compounds, 
as determined by in silico analysis, while the interaction with DHPS of C. albicans could not be discussed because 
the three dimensional structure of DHPS of C. albicans was not available in the PDB.  
3.3. Validation of the docking 
In the molecular docking experiment, to ensure that ligand conformations bound correctly with the binding 
pocket of the target protein, the size and position of the grid box had to be validated. In this work, docking 
validation was carried out by redocking the co-crystallized DHPS-sulfanilamide complex (PDB:1AJ0)16 for E. coli, 
and the co-crystallized DHPS-6-hydroxymethylpterin diphosphate complex for S. aureus (PDB:1AD4).17 We found 
that the binding conformations of both redocked complexes reproduced the binding modes of the co-crystallized 
complexes with binding affinities –2.91 kcal/mol (RMSD = 1.58 ǖ) for E. coli, and –7.33 kcal/mol (RMSD = 0.83 
ǖ) for S. aureus. 
According to Achary et al.16, the 7,8-dihydropterin pyrophosphate substrate bound in a deep cleft in the barrel, 
while sulphanilamide bound closer to the surface. Precisely, the sulphanilamide in the E. coli DHPS binding site was 
sandwiched between the main chain of Arg220 and the side chain of Lys221 on one side and the side chain of Arg63 
on the other. The sulphonamide NH2 formed a hydrogen bond to the carbonyl of Ser219, while sulphonamide 
oxygen accepted a hydrogen bond from the guanidinium of Arg63. Our redocking experiment provided the 
following observation: the sulphanilamide was flanked between the side chain of Lys221 and the main chain of 
Thr62. The hydrogen of aminophenyl moiety of sulphanilamide NH2 donated a hydrogen bond with the carbonyl of 
Thr62, while the hydrogen of sulphonamide donated a hydrogen bond with the carbonyl of Ser219. Hydrophobic 
interactions were observed between sulphanilamide and Thr62, Phe190, Arg220, and Lys221. 
Fig. 1. Histogram of the average of inhibition zone 
diameter and notation of the seven prepared 
compounds and two positive controls against E.  coli, 
S. aureus, and C. albicans according to the Kruskal-
Wallis test. SD = sulfadiazine, SM = sulfamerazine 
 
 Hery Suwito et al. /  Procedia Chemistry  18 ( 2016 )  103 – 111 107
According to Hampele et al.17, the interactions of hydroxymethylpterin pyrophosphate with amino acid residues 
of the S. aureus binding site occurred through polar and hydrophobic interactions. Amino acid residues involved in 
the polar interactions with the pterin moiety of the ligand were Asp167, Asn103, Lys203 and Asp84. The primary 
amine on C-2 and the protonated nitrogen at N-3 donated hydrogen bonds to the carboxylate oxygen atom of 
Asp167. Again the 2-NH2 group donated a hydrogen bond with the side-chain oxygen of Asn103, while the NH 
group of Asn103 built a hydrogen bond with N-1 of the pterin. Lys203 donated its hydrogen atom to form a 
hydrogen bond with the oxygen atom of the carbonyl group of the pterin and with the N-5. Asp84 donated a 
hydrogen bond to the N-8 of the pterin moiety. Our redocking experiment conferred the following observation: the 
interactions observed between S. aureus DHPS binding site with 6-hydroxymethylpterin diphosphate are explained 
as follows: 6-hydroxymethylpterin diphosphate built hydrophobic interactions with Ile9, Asn11, Arg52, Asp84, 
Asn103, Met128, Asp167, Phe172, Lys203, Arg239 and His241, while hydrogen bonds existed between the 
pyrophosphate moiety and four amino acid residues, which were Arg52, Lys203, Arg239, and His241; Arg52 with 





Fig. 2. Redocking of sulphanilamide into E. coli DHPS (a) and 6-hydroxymethylpterin diphosphate into S. aureus DHPS (b). The docking poses 
of the ligand are shown in green carbons. Residues with hydrophobic contacts with sulphanilamide and 6-hydroxymethylpterin diphosphate are 
labelled in grey while hydrogen bonds are shown in yellow with dashed lines. 
 
3.4. Docking of the title compounds 
In this work we performed molecular docking on 9 compounds, which were 7 derivatives of methoxy-4’-amino 
chalcone, sulfadiazine, and sulfamerazine. The results presenting the docking poses are displayed in Fig. 2, while 
the docking results and molecular interactions between tested compounds with amino acid residues of DHPS 
binding site are tabulated in the Table 2.  
General observation of the docking results provided that the tested chalcone derivatives exhibited preponderant 
affinity with DHPS of S. aureus than with E. coli (based on the data of binding affinity). Three dimensional 
structural complementarities between the protein binding site and the ligands is also one of the important factors 
determining the binding affinity. Based on the sequence alignment of DHPS of E. coli and S. aureus, only 36% of 
homology was identified. This results provided that DHPS of both microbes were similar but not identical (Fig. 3), 
and the three dimensional structures of their binding sites differed consequently. In addition, all the tested 
compounds were bound in the deep cleft of the binding site, which was in accordance with the binding location of 
hydroxymethylpterin pyrophosphate. This information gave us an understanding that the prepared compounds, 
which were designed as competitive inhibitors of PABA, were more suitable to dock into a hydroxymethylpterin 
pyrophosphate binding location than into a sulphanilamide binding location. 
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Fig. 4. Superimposed 3D-structure between DHPS of E. coli (pink) and S. aureus (blue). 
 
In this article we discuss the docking results of compounds 4, 2 and 7. The reasons for the choice of these 
compounds were shown by the antimicrobial test, in which compound 4 (a dimethoxy-4’-amino chalcone derivative) 
displayed good potential to be used as a wide spectrum antimicrobial agent, compound 2 representing a 
monomethoxy-4’-amino chalcone derivative, and compound 7 representing 4’-amino chalcone derivative. 
The factors considered for the scoring function in AutoDock4 were van der Waals interactions, electrostatic 
interactions, hydrogen bonds, desolvation, and rotations16. Besides hydrogen bonds, from the docking experiment 
we also obtained data about van der Waals and electrostatic interaction, which are not displayed in the Table 2. 
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Table 2. Docking results and molecular interactions between tested compounds with amino acid residues of DHPS. 
Comp DHPS E. coli DHPS S. aureus
ǻG (kcal/mol) Hydrogen bond interactions ǻG (kcal/mol) Hydrogen bond interactions 
NS -2.91 Thr62, Ser219 -7.33 Asn11, Asp84, Asn103, Lys203, Arg239, His241 
1 -3.13 Pro145 -6.23 Asn103, Asp167, Lys203 
2 -2.19 Thr62, Pro145 -6.48 Asn103, Asp167, Lys203 
3 -1.05 Thr62, Pro145 -6.19 Asn103, Asp167, Lys203 
4 -2.05 Thr62, Pro145 -6.10 Asn103, Asp167, Lys203 
5 -1.09 Thr62, Pro145 -6.11 Asn103, Asp167, Lys203, Arg239 
6 -0.66 --- -6.47 Asn103, Asp167, Lys203 
7 -3.57 Pro145 -6.23 Asn103, Asp167, Lys203 
SD -3.25 Thr62, Arg63 -6.31 Val49, Asp84, Lys203 
SM -3.12 Thr62, Arg63 -6.08 Asn103, Asp167, Arg239 






Fig. 5. Docking poses and intermolecular interactions of compound 2, 4 and 7 in DHPS binding sites. (a) E. coli, (b) S. aureus. The docking poses 
of the ligand are shown in green carbons. Residues with hydrophobic contacts with tested compounds are labelled in grey while hydrogen bonds 
are shown in grey with dashed lines. 
3.4.1. Docking into E. coli DHPS (Figure 4a)  
Compound 2: The location of ring A of compound 2 was flanked by the side chain of Gly189 and Arg63, whilst 
the ring B was located near the side chain of Lys221. The primary amino group of compound 2 donated hydrogen 
bonds to the carbonyl groups of Thr62 and Pro145. The position of the methoxy group was pointing to the 
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guanidinium moiety of Arg220. The amino acid residue Thr62, Arg63, Pro64, Pro145, Gly189, Arg220, Lys221, 
Ser222, and His257 contributed to hydrophobic interactions. 
Compound 4: The position of ring A of compound 4 was flanked by the side chain of Arg63 and Pro64, whilst 
ring B was near the side chain of Lys221. The primary amino group of compound 4 made a bifurcated hydrogen 
bond with the carbonyl groups of Thr62 and Pro145. One methoxy group pointed to the guanidinium moiety of 
Arg63 and another pointed to the guanidinium moiety of Arg220. Amino acid residues Thr62, Arg63, Pro64, 
Pro145, Gly189, Arg220, Lys221, Ser222 and His257 contributed to hydrophobic interactions. 
Compound 7: The side chain of Phe190 and Arg63 flanked the ring A of compound 7, while ring B was flanked 
by the side chains of Pro232 and Arg220. The primary amino group of compound 7 donated a hydrogen bond to the 
carbonyl group of Pro145. The amino acid residues involved in the formation of hydrophobic interactions were 
Thr62, Arg63, Pro64, Pro145, Phe190, Arg220, Lys221, Pro232 and His257. 
3.4.2. Docking into S. aureus DHPS (Figure 4b) 
Compound 2: The ring A of compound 2 was in a twisted conformation relative to ring B and was flanked by the 
side chains of three amino acid residues, Gln105, Asp167, and Ala199, whilst ring B was flanked by Asn103 and 
Arg239. The methoxy group pointed to the side chain of Asn11. The primary amino group of compound 2 made a 
bifurcated hydrogen bond with the carbonyl group of side chains of Asp167 and Asn103, while the carbonyl group 
of compound 2 acted as a hydrogen acceptor in the hydrogen bond with the amino group of the side chain of 
Lys203. Non-polar interactions were contributed by Asn11, Gly47, Val49, Asp84, Asn103, Gln105, Met128, 
Asp167, Phe172, Ala199, Lys203 and Arg239.  
Compound 4: The ring A of compound 4 was flanked by the side chains of the amino acid residues Gln105, 
Arg239, and Ala199, whilst the ring B was flanked by Val49 and Ser40. The position of the two methoxy groups 
was pointing to Asn11 and His55. The amino group of compound 4 donated its two hydrogen atoms to the formation 
of hydrogen bonds with the side chain carbonyl groups of Asn103 and Asp167, while the carbonyl group of 
compound 4 acted as a hydrogen acceptor of the side chain amino group of Lys203 in hydrogen bond formation. 
The following amino acid residues Asn11, Val49, Ser50, His55, Asp84, Asn103, Gln105, Met128, Asp167, Phe172, 
Ala199, Lys203 and Arg239 contributed to hydrophobic interactions. 
Compound 7: The ring A of compound 7 was located in the area flanked by Phe172, Asn103, and Ala199, while 
ring B was flanked by Val19 and Arg239. The amino group of compound 7 donated hydrogen bonds with the side 
chain carbonyl group of Asn103 and Asp167. The carbonyl group of compound 7 acted as a hydrogen acceptor of 
the side chain amino group of Lys203 in hydrogen bond formation. The hydrophobic interactions were contributed 
by the following amino acid residues: Asn11, Val49, Asp84, Asn103, Gln105, Met128, Asp167, Phe172, Ala199, 
Lys203 and Arg239. 
The docking results showed that the amino acid residues involved actively in the molecular interaction from the 
docking experiment were in accordance with the results of protein-ligand complexes that were co-crystallized. 
4. Conclusions 
The antimicrobial activities of the methoxy amino chalcone derivatives have been assayed and their molecular 
interaction with the E. coli and S. aureus DHPS were studied with a docking experiment using the AutoDock4 
program. Compound 4, (E)-1-(4-aminophenyl)-3-(2,3-dimethoxyphenyl)prop-2-en-1-one), exhibited a promising 
wide spectrum antimicrobial activity. The docking experiment gave us information that the prepared compounds 
were docked in the binding location of hydroxymethylpterin pyrophosphate in the DHPS binding site.  
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